Mitomycin C for prevention of postoperative haze following excimer laser surface ablation in moderate to high myopia
Referencias
Additional references
Ambrósio R, Wilson S. LASIK vs LASEK vs PRK: advantages and indications. Seminars in Ophthalmology 2003;18(1):2‐10.
Argento C, Cosentino MJ, Ganly M. Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. Journal of Refractive Surgery 2006;22(8):782‐6.
Bedei A, Marabotti AB, Giannecchini I, Ferretti C, Montagnani M, Martinucci C, et al. Photorefractive keratectomy in high myopic defects with or without intraoperative mitomycin C:1 year results. European Journal of Ophthalmology 2006;16(2):229‐34.
Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin‐C to inhibit haze formation after photorefractive keratectomy. Journal of Cataract and Refractive Surgery 2002;28(12):2088‐95.
Claringbold TV. Laser‐assisted subepithelial keratectomy for the correction of myopia. Journal of Cataract and Refractive Surgery 2002;18(1):18‐22.
Diakonis VF, Pallikaris A, Kymionis GD, Markomanolakis MM. Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. American Journal of Ophthalmology 2007;144(1):99‐103.
Fantes FE, Hanna KD, Waring GO, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Archives of Ophthalmology 1990;108(5):665‐75.
Gamaly TO, El Danasoury A, El Maghraby A. A prospective, randomized, contralateral eye comparison of epithelial laser in situ keratomileusis and photorefractive keratectomy in eyes prone to haze. Journal of Refractive Surgery 2007;23(Suppl 9):1015‐20.
Gimbel HV, Levy SG. Indications, results, and complications of LASIK. Current Opinion in Ophthalmology 1998;9(4):3‐8.
Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6.
Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, et al. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. Journal of Refractive Surgery 2007;23(7):724‐7.
Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Joo MJ, Kim YN, Hong HC, Ryu DK, Kim JH. Simultaneous laser in situ keratomileusis on the stromal bed and undersurface of the flap in eyes with high myopia and thin corneas. Journal of Cataract and Refractive Surgery 2005;31(10):1921‐7.
Kim TI, Pak JH, Lee SY, Tchah H. Mitomycin C‐induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Investigative Ophthalmology & Visual Science 2004;45(9):2978‐84.
Kim TI, Lee SY, Pak JH, Tchah H, Kook MS. Mitomycin C, ceramide, and 5‐fluorouracil inhibit corneal haze and apoptosis after PRK. Cornea 2006;25(1):55‐60.
Kuo IC, Lee SM, Hwang DG. Late‐onset corneal haze and myopic regression after photorefractive keratectomy (PRK). Cornea 2004;23(4):350‐5.
Lee DH, Chung HS, Jeon YC, Boo SD, Yoon YD, Kim JG. Photorefractive keratectomy with intraoperative mitomycin C application. Journal of Cataract and Refractive Surgery 2005;31(12):2293‐8.
Majumdar PA, Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R, et al. Topical mitomycin‐C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000;107(1):89‐94.
Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long‐term keratocyte density in rabbits. Journal of Refractive Surgery 2006;22(6):562‐74.
O'Connor J, O'Keeffe M, Condon PI. Twelve‐year follow‐up of photorefractive keratectomy for low to moderate myopia. Journal of Refractive Surgery 2006;22(9):871‐7.
Pallikaris IG, Siganos DS. Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. Journal of Refractive and Corneal Surgery 1994;10(5):498‐510.
Palliakris IG, Naoumidi II, Kalyvianaki MI, Katsanevaki VJ. Epi‐LASIK: comparative histological evaluation of mechanical and alcohol‐assisted epithelial separation. Journal of Cataract and Refractive Surgery 2003;29(8):1496‐1501.
Shortt AJ, Allan BDS. Photorefractive keratectomy (PRK) versus laser‐assisted in‐situ keratomileusis (LASIK) for myopia. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005135.pub2]
Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark WJ. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Archives of Ophthalmology 1991;109(8):1141‐6.
Taneri S, Zieske JD, Azar DT. Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature. Survey of Ophthalmology 2004;49(6):576‐602.
Thornton I, Xu M, Krueger RR. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. Journal of Refractive Surgery 2008;24(1):S68‐S76.
Tuli SS, Iyer S. Delayed ectasia following LASIK with no risk factors: is a 300‐microm stromal bed enough?. Journal of Refractive Surgery 2007;23(6):620‐2.
